Sign in
4

Changes in Ownership

Definium Therapeutics, Inc. Filed Acc 0001193125-26-285562

Chief Executive Officer sold 29,208 shares at $45.03 ($1,315,236)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Barrow Robert · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-06-25 Sale : show line 1 in the form 10b5-1 −29,208 $45.03 $1,315,236 1,098,246 D
Open-market sales · 29,208 sh · avg $45.03 · $1,315,236
Loading xslF345X06/ownership.xml…